Muscle & Brawn 2.0 is live! New Tools, Voice Reader, Compound Index, Features and more on the way. Want to explore what’s new → Click Here
Independent & reader-supported — every article medically reviewed

Cycle support / 5-alpha-reductase inhibitors

9 In the index

Finasteride FIN

An FDA-approved medication for male pattern hair loss and enlarged prostate, working by blocking a hormone that shrinks hair follicles. Human trials confirm it regrows hair and helps the prostate, but it also carries a well-documented, sometimes lasting risk of sexual and mood side effects in some users, even after stopping.

Also known as Propecia, Proscar, Finastid, Prostide, Chibro-Proscar, Finasterida, Finpecia

Routes Oral
Legal status Prescription drug
WADA Not listed

3D Molecular Structure of C23H36N2O2

Drag to rotate · scroll to zoom

  • Carbon
  • Hydrogen
  • Nitrogen
  • Oxygen

Chemistry

Formula
C23H36N2O2
Molar mass
372.5
CAS
98319-26-7
PubChem CID
57363
IUPAC name
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
InChIKey
DBEPLOCGEIEOCV-WSBQPABSSA-N

Reported dosing

Approved label

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 1 mg/day (hair loss) or 5 mg/day (BPH)
Reported range 1-5 mg/day depending on indication
Route Oral
Frequency Once daily
Duration Chronic/ongoing (as prescribed)

FDA-approved 5-alpha-reductase inhibitor (Propecia/Proscar); associated in some users with persistent sexual side effects even after stopping (post-finasteride syndrome), a recognized safety signal.

Where this comes from FDA prescribing information

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.